• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环状RNA在血液系统恶性肿瘤中的作用。

The role of circular RNAs in hematological malignancies.

作者信息

Lin Zhi, Long Fei, Zhao Mingyi, Zhang Xueyan, Yang Minghua

机构信息

Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Department of Pediatrics, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.

Department of Gastrointestinal Surgery, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.

出版信息

Genomics. 2020 Nov;112(6):4000-4008. doi: 10.1016/j.ygeno.2020.06.051. Epub 2020 Jul 4.

DOI:10.1016/j.ygeno.2020.06.051
PMID:32634468
Abstract

Circular RNAs (circRNAs) are a class of noncoding RNAs (ncRNAs) that lack a 5' end cap or a 3' end poly-(A) tail and form a circular structure through covalent bonds. Compared to linear RNAs, circRNAs are more conservative and stable, and their distribution is spatiotemporally regulated. circRNAs, as a new type of competitive endogenous RNA (ceRNA), are involved in many disease processes and are also related to the occurrence and development of tumors. Over the past three years, the role of circRNAs in hematological malignancies has received increasing attention. Related research has shown that circRNAs may regulate the occurrence and development of hematological malignancies and contribute to drug resistance through a variety of molecular mechanisms. Therefore, to lay the foundation and point out directions for further research on circRNAs, this article systematically reviews the research progress on circRNAs in leukemia, lymphoma, and myeloma.

摘要

环状RNA(circRNAs)是一类非编码RNA(ncRNAs),它们缺乏5'端帽或3'端多聚(A)尾,并通过共价键形成环状结构。与线性RNA相比,circRNAs更保守、更稳定,其分布受时空调节。circRNAs作为一种新型的竞争性内源RNA(ceRNA),参与许多疾病过程,也与肿瘤的发生和发展有关。在过去三年中,circRNAs在血液系统恶性肿瘤中的作用越来越受到关注。相关研究表明,circRNAs可能通过多种分子机制调节血液系统恶性肿瘤的发生和发展,并导致耐药性。因此,为了为circRNAs的进一步研究奠定基础并指明方向,本文系统综述了circRNAs在白血病、淋巴瘤和骨髓瘤中的研究进展。

相似文献

1
The role of circular RNAs in hematological malignancies.环状RNA在血液系统恶性肿瘤中的作用。
Genomics. 2020 Nov;112(6):4000-4008. doi: 10.1016/j.ygeno.2020.06.051. Epub 2020 Jul 4.
2
From circRNAs to fusion circRNAs in hematological malignancies.从环状 RNA 到血液系统恶性肿瘤中的融合环状 RNA。
JCI Insight. 2021 Nov 8;6(21):e151513. doi: 10.1172/jci.insight.151513.
3
The research progress of circular RNAs in hematological malignancies.环状RNA在血液系统恶性肿瘤中的研究进展
Hematology. 2019 Dec;24(1):727-731. doi: 10.1080/16078454.2019.1669924.
4
The functions and clinical significance of circRNAs in hematological malignancies.环状 RNA 在血液系统恶性肿瘤中的功能及临床意义。
J Hematol Oncol. 2020 Oct 17;13(1):138. doi: 10.1186/s13045-020-00976-1.
5
[Recent Research Progress on CircRNA in Hematological Malignancies--Review].[环状RNA在血液系统恶性肿瘤中的研究进展——综述]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Jun;31(3):927-930. doi: 10.19746/j.cnki.issn.1009-2137.2023.03.047.
6
Advances in the Study of circRNAs in Hematological Malignancies.血液系统恶性肿瘤中环状RNA的研究进展
Front Oncol. 2022 Jun 20;12:900374. doi: 10.3389/fonc.2022.900374. eCollection 2022.
7
Functions of circular RNAs and their potential applications in gastric cancer.环状 RNA 的功能及其在胃癌中的潜在应用。
Expert Rev Gastroenterol Hepatol. 2020 Feb;14(2):85-92. doi: 10.1080/17474124.2020.1715211. Epub 2020 Jan 14.
8
Role of circular RNA in hematological malignancies.环状RNA在血液系统恶性肿瘤中的作用。
Oncol Lett. 2019 Nov;18(5):4385-4392. doi: 10.3892/ol.2019.10836. Epub 2019 Sep 10.
9
Role of circRNAs in viral infection and their significance for diagnosis and treatment (Review).环状 RNA 在病毒感染中的作用及其在诊断和治疗中的意义(综述)。
Int J Mol Med. 2021 May;47(5). doi: 10.3892/ijmm.2021.4921. Epub 2021 Mar 31.
10
Circular RNAs function as ceRNAs to regulate and control human cancer progression.环状 RNA 作为 ceRNA 调节和控制人类癌症的进展。
Mol Cancer. 2018 Apr 7;17(1):79. doi: 10.1186/s12943-018-0827-8.

引用本文的文献

1
Circular RNAs and Cancers.环状RNA与癌症
Adv Exp Med Biol. 2025;1485:273-327. doi: 10.1007/978-981-96-9428-0_18.
2
Cancer fusion transcripts with human non-coding RNAs.与人类非编码RNA相关的癌症融合转录本。
Front Oncol. 2024 Jun 11;14:1415801. doi: 10.3389/fonc.2024.1415801. eCollection 2024.
3
Curcumin in treatment of hematological cancers: Promises and challenges.姜黄素治疗血液系统癌症:前景与挑战
J Tradit Complement Med. 2024 Jan 5;14(2):121-134. doi: 10.1016/j.jtcme.2023.10.004. eCollection 2024 Mar.
4
Circular RNAs: pivotal role in the leukemogenesis and novel indicators for the diagnosis and prognosis of acute myeloid leukemia.环状RNA:在白血病发生中的关键作用及急性髓系白血病诊断和预后的新指标
Front Oncol. 2023 Apr 14;13:1149187. doi: 10.3389/fonc.2023.1149187. eCollection 2023.
5
Protects Acute Myeloid Leukemia Cells from Ferroptotic Cell Death by Upregulating SCD.通过上调硬脂酰辅酶A去饱和酶(SCD)保护急性髓系白血病细胞免受铁死亡细胞死亡
Cancers (Basel). 2023 Jan 11;15(2):459. doi: 10.3390/cancers15020459.
6
Advances in the Study of circRNAs in Hematological Malignancies.血液系统恶性肿瘤中环状RNA的研究进展
Front Oncol. 2022 Jun 20;12:900374. doi: 10.3389/fonc.2022.900374. eCollection 2022.
7
CircRNAs: novel therapeutic targets in multiple myeloma.环状 RNA:多发性骨髓瘤的新型治疗靶点。
Mol Biol Rep. 2022 Nov;49(11):10667-10676. doi: 10.1007/s11033-022-07668-8. Epub 2022 Jun 21.
8
Circular RNA and Its Roles in the Occurrence, Development, Diagnosis of Cancer.环状RNA及其在癌症发生、发展和诊断中的作用。
Front Oncol. 2022 Apr 7;12:845703. doi: 10.3389/fonc.2022.845703. eCollection 2022.
9
Involvement of CircRNA Expression Profile in Diabetic Retinopathy and Its Potential Diagnostic Value.环状RNA表达谱在糖尿病视网膜病变中的作用及其潜在诊断价值
Front Genet. 2022 Feb 17;13:833573. doi: 10.3389/fgene.2022.833573. eCollection 2022.
10
Silencing circular RNAPTPN12 promoted the growth of keloid fibroblasts by activating Wnt signaling pathway via targeting microRNA-21-5p.沉默环状 RNA PTPN12 通过靶向 microRNA-21-5p 激活 Wnt 信号通路促进瘢痕疙瘩成纤维细胞的生长。
Bioengineered. 2022 Feb;13(2):3503-3515. doi: 10.1080/21655979.2022.2029108.